It’s confirmed: Amarin loses Vascepa patent appeal, putting generics defense on life support kblankenship Thu, 09/03/2020 – 09:54

Biotech CEOs pen standards for coronavirus trials, data disclosures amid FDA reputation crisis esagonowsky Thu, 09/03/2020 – 09:38

A new technology that uses a protein’s structure to predict the inner wiring that controls the protein’s function […]

For patients who receive a heart transplant in the near future, the old adage, ‘Good things come in […]

A new study uses magnetic resonance elastography to compare the stiffness of the hippocampus in patients who have […]

The humble ink in a tattoo artist’s needle could be the key to improving the detection of cancer, […]

Scientists have discovered that hard-to-treat pancreatic cancer hijacks a key immune system response

UK MHRA has issued positive scientific opinion enabling the drug’s inclusion on the Early Access to Medicines Scheme

NICE has concerns with the evidence submitted but Janssen insists the nasal spray is a cost-effective use of […]

Over 400 participants are being enrolled in the Phase I/II study after promising preclinical safety and immunogenicity data